POSTER SESSION III
Tuesday, March 20, 2012 — 9:30 AM - 12:00 Noon
CC Exhibit Hall B3 & C
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GENITOURINARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
143
Tyrosine Kinase Inhibitor-Induced Vasculopathy in Clear Cell Renal Cell Carcinoma as an Anti-Tumor Mechanism
(1034)
T Tsuzuki, N Sassa, T Morikawa, A Fukatsu, Y Yoshino, R Hattori, R Shiroki, M Gotoh - Nagoya Daini Red Cross Hospital, Nagoya, Japan; Nagoya University, Nagoya, Japan; Fujita Health University, Toyoake, Japan; Komaki Municipal Hospital, Komaki, Japan
Clinicopathologic Characteristics of Renal Cell Carcinoma in Patients 45 Years of Age and Younger
(811)
R Carr, A Van Dyke, G Cai, K Haines, AJ Adeniran - Yale University School of Medicine, New Haven, CT
ALK Alterations in Adult Renal Cell Carcinoma: Frequency, Clinicopathologic Features and Outcome in a Large Series of Consecutively Treated Patients
(1020)
WR Sukov, JC Hodge, CM Lohse, MK Akre, BC Leibovich, H Thompson, JC Cheville - Mayo Clinic, Rochester, MN
Xp11.2 Translocations in Adult Renal Cell Carcinomas with Clear Cell and Papillary Features
(814)
SM Chan, MY Gabril, IJ Zbieranowski, LM Sugar, GM Yousef, GA Bjarnason, CG Sherman - Univ. of Toronto, Toronto, Canada; Univ. of Western Ontario, London, Canada
Development of a TFEB Break-Apart Fluorescence In Situ Hybridization (FISH) Assay for Diagnosis of the t(6;11) (p21;q12) Renal Cell Carcinomas Harboring the Alpha-TFEB Gene Fusion in Archival Material
(788)
P Argani, R Yonescu, GJ Netto, PB Illei, CA Griffin - Johns Hopkins Medical Institutions, Baltimore, MD
Immunohistochemical Profile of Renal Cell Carcinoma in Patients Younger than 45 Years of Age: Analysis of 87 Cases of Different Tumor Subtypes
(812)
R Carr, G Cai, Y Bao, ML Prasad, SK Tickoo, AJ Adeniran - Yale University School of Medicine, New Haven, CT
Polybromo 1 (PBRM1) Expression in Renal Epithelial Neoplasms (REN) by Immunohistochemistry
(1029)
M Tretiakova, M Kocherginsky, SE Eggener, AL Shalhav, T Antic, GP Paner - University of Chicago, Chicago
Unclassified Renal Cell Carcinoma and Invasive High Grade Urothelial Carcinoma: Is the Distinction Possible by Immunohistochemistry and Clinically Important?
(1053)
KE Watts, JP Reynold, P Carver, M Zhou - Cleveland Clinic, Cleveland, OH
Expression of Novel Markers Human Kidney Injury Molecule-1 (Hkim-1), S100A1 and Napsin A in the Differential Diagnosis of Renal Cell Carcinomas (RCC) with Clear and Papillary Features
(790)
M Aron, M Amin, P Zhang, M DePeralta-Venturina, SK Mohanty, S Wang, MB Amin - Cedars-Sinai Medical Center, Los Angeles, CA; William Beaumont Hospital, Detroit
Immunohistochemical Profile of Clear Cell and Related Renal Cell Cancers, with Emphasis on CK7 and Carbonic Anhydrase-IX (CA-IX) Staining
(850)
SW Fine, Y Chen, HA Al-Ahmadie, A Gopalan, VE Reuter, SK Tickoo - Memorial Sloan-Kettering Cancer Center, New York, NY
Current Immunomarkers Are Inadequate for Accurate Classification of Renal Epithelial Tumors
(888)
C Himmetoglu Ussakli, L True - University of Washington, Seattle, WA
How Immunohistochemistry Can Help To Identify Renal Tumors Associated with SDHB Syndrome
(1046)
BA Walter, VA Valera, K Pacak, M Linehan, MJ Merino - NCI, NIH, Bethesda
PAX8 Mouse Monoclonal Antibody: A Comprehensive and Comparative Study on Normal and Neoplastic Tissues
(1022)
D Tacha, D Zhou, R Bremer, L Cheng - Biocare Medical, Concord, CA; Indiana School of Medicine, Indianapolis, IN
The Relationship between EZH2 Expression and Renal Cell Carcinoma
(932)
HW Lee, JY Park, I Hwang, HR Jung, SY Kwon, YN Kang, SP Kim, K Kwon, SS Lee, MS Choe - Keimyung University School of Medicine, Daegu, Korea
Molecular Classification Helps Discriminate between Oncocytomas and Chromophobe Renal Carcinomas Using Meta-Analysis of Gene Expression Microarrays
(1039)
VA Valera Romero, BA Walter Rodriguez, MJ Merino - National Cancer Institute, National Institutes of Health, Bethesda, MD
Worrisome Histologic Features in Benign Renal Oncocytoma: Immunohistochemical and Cytogenetic Analysis
(810)
M Brunelli, M Ficial, D Segala, E Munari, S Pedron, S Gobbo, M Chilosi, A Yilmaz, K Trpkov, B Delahunt, JN Eble, L Cheng, G Martignoni - University of Verona, Verona, Italy; University of Calgary, Calgary, AB, Canada; University of Otago, Wellington, New Zealand; Indiana University, Indianapolis, IN
Pigmented Microcystic Chromphobe Renal Cell Carcinoma: A Peculiar Morphological Variant. Clinicopathologic, Immunohistochemical, and Molecular Cytogenetic Study of 33 Cases
(984)
FJ Queipo, A Panizo, A Tienza, I Rodriguez, JJ Sola, J Pardo - Clinica Universidad de Navarra, Pamplona, Spain; Complejo Hospitalario de Navarra ´A´, Pamplona, Spain
Expression of the Na+/K+-Transporting ATPase Gamma Subunit FXYD2 in Chromophobe Renal Cell Carcinoma and Renal Oncocytoma
(859)
JP Gaut, DL Crimmins, CM Lockwood, JJ McQuillan, JH Ladenson - Washitngton University School of Medicine, St. Louis, MO
´Hybrid Oncocytic/Chromophe Renal Cell Tumours´ Do Not Display Genomic Features of Chromophobe Carcinomas
(1045)
A Vieillefond, N Pote, F Mege-Lechevallier, M Sibony, P Camparo, V Molinie, J Couturier - Hopital Cochin, Paris, France; Hopital Edouard Herriot, Lyon, France; Curie Institute, Paris, France; Hopital Foch, Suresnes, France; Hopital Saint-Joseph, Paris, France
Cytogenomic Analysis Is a Useful Adjunct Diagnostic Tool for Difficult Renal Oncocytic Tumors
(980)
AL Peterson, A Ayala, JY Ro, SS Shen, LD Truong, FA Monzon - The Methodist Hospital, Houston, TX
Open and Robotic/Laparoscopic Partial Nephrectomy: A Large Single-Institutional Experience with Clinicopathologic Analysis and Follow-Up
(936)
L Liu, JG Pattaras, AO Osunkoya - Emory University School of Medicine, Atlanta
All New Antiangiogenic Therapies Can Induce ´Preeclampsia- Like Syndrome´
(991)
N Rioux-Leclercq, T Dolley-Hitze, N Lorcy, M-A Belaud- Rotureau, F Jouan, C Vigneau - CHU Pontchaillou, Rennes Cedex 9, France; Institut Génétique et Développement de Rennes, Rennes, France
Sarcomatoid Renal Cell Carcinoma Shows a Distinct Transcriptomic Profile That Is Not Associated with Epithelial to Mesenchymal Transition Markers
(1013)
K Sircar, T Majewski, K Wani, J McDonald, K Baggerly, P Tamboli, B Czerniak, K Aldape - University of Texas MD Anderson Cancer Center, Houston, TX
Immunohistochemical Profile of Stem/Progenitor Cell Marker C133 in Variants of Renal Tumors
(1006)
JD Schwartz, MB Amin, PL Zhang - William Beaumont Hospital, Royal Oak, MI; Oakland University William Beaumont School of Medicine, Rochester, MI
button next to any title to add to Itinerary Planner...
Add
